We read with great pleasure the paper by Pokorney et al. ([1][1]), regarding how the use of oral anticoagulants (OACs) may not actually reduce the risk of death or stroke and… Click to show full abstract
We read with great pleasure the paper by Pokorney et al. ([1][1]), regarding how the use of oral anticoagulants (OACs) may not actually reduce the risk of death or stroke and is adversely associated with a higher risk of hospitalization in patients with end-stage renal disease (ESRD). The study
               
Click one of the above tabs to view related content.